Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Prime Medicine Q2 EPS $(0.46) Misses $(0.41) Estimate

Author: Benzinga Newsdesk | August 08, 2024 08:07am
Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.41) by 12.2 percent. This is a 2.13 percent increase over losses of $(0.47) per share from the same period last year.

Posted In: PRME


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist